Stocks股票 / Health Care / NEOG
NEOG US listed · USD美股 · 美元
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan.Neogen Corporation是一家国际食品安全公司,提供检测食品中有害物质的测试工具及相关产品。公司成立于1982年,总部位于密歇根州兰辛。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-04Estimates being raised — 1 analysts预期上调 — 1 位分析师
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | NEOG | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 1.03x | 3.44 | |
| FCF yield自由现金流收益率 | -2.13% | 4.00 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Signal history信号历史
engine events引擎事件Company profile公司档案
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan.Neogen Corporation是一家国际食品安全公司,提供检测食品中有害物质的测试工具及相关产品。公司成立于1982年,总部位于密歇根州兰辛。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 1.0× | 3.4× | 96% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +3.7% | -0.9% |
| 1 Month近1月 | +7.5% | -0.6% |
| 3 Months近3月 | +6.3% | +5.4% |
| 6 Months近6月 | +1.4% | +8.6% |
| Year to date年初至今 | +43.0% | +8.9% |
| 1 Year近1年 | +111.2% | +19.2% |
| 3 Years近3年 | -55.6% | +69.9% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $418M | $468M | $527M | $822M | $924M | $895M |
| EPS每股收益 | $1.13 | $0.57 | $0.45 | $-0.12 | $-0.04 | $-5.03 |
| Free cash flow自由现金流 | $62M | $54M | $44M | $-25M | $-76M | $-46M |
| Gross margin毛利率 | 46.9% | 45.9% | 46.1% | 49.4% | 50.2% | 47.1% |
| Net margin净利率 | 14.2% | 13.0% | 9.2% | -2.8% | -1.0% | -122.1% |
| FCF margin自由现金流利润率 | 14.8% | 11.6% | 8.3% | -3.0% | -8.2% | -5.2% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin +0.2pts over 6 years定价能力:毛利率 6 年上升 0.2 个百分点
- Capital discipline: share count +314.8% over 6 years (dilution)资本纪律:股本 6 年增加 314.8%(稀释)
- Balance sheet: Altman Z 0.12 — distress zone资产负债表:Altman Z 0.12——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Insiders & shorts内部人与空头
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -5.0% | 3 |
| Feb2月 | 67% | +9.6% | 3 |
| Mar3月 | 0% | -13.7% | 3 |
| Apr4月 | 33% | -23.4% | 3 |
| May5月 | 67% | +6.9% | 3 |
| Jun6月 | 75% | +4.7% | 4 |
| Jul7月 | 75% | +9.4% | 4 |
| Aug8月 | 100% | +2.1% | 3 |
| Sep9月 | 33% | -2.0% | 3 |
| Oct10月 | 33% | -15.2% | 3 |
| Nov11月 | 67% | +0.3% | 3 |
| Dec12月 | 67% | +16.5% | 3 |